ADHD update: new data on the risks of medication.
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D000328:Adult; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002648:Child; D016757:Death, Sudden, Cardiac / Q000209:etiology; D062787:Drug Overdose / Q000209:etiology; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects / Q000031:analogs & derivatives; D011437:Propylamines / Q000009:adverse effects
D018759:Adrenergic Uptake Inhibitors; D000697:Central Nervous System Stimulants; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride